Search Results for “” – Page 11 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Model

118 Publications found

High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysis.

b

Health technology assessment (Winchester, England)

June 1, 2015

p Cardiovascular Disease

c Economics Model
Outcome and economic implications of proteomic test-guided second- or third-line treatment for advanced non-small cell lung cancer: extended analysis of the PROSE trial.

b

Lung cancer (Amsterdam, Netherlands)

May 1, 2015

p Cancer

c Clinical outcomes Economics Model
Cost-effectiveness of multiplexed predictive biomarker screening in non-small-cell lung cancer.

b

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

April 1, 2015

p Cancer

c Economics Model
Cost-effectiveness of newborn screening for cystic fibrosis determined with real-life data.

b

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

March 1, 2015

p Newborn Screening

c Economics Model
Personalised treatment using serum drug levels of adalimumab in patients with rheumatoid arthritis: an evaluation of costs and effects.

b

Annals of the rheumatic diseases

February 1, 2015

p Therapeutic drug monitoring

c Economics Model
Cost savings of anti-TNF therapy using a test-based strategy versus an empirical dose escalation in Crohn’s disease patients who lose response to infliximab.

b

Journal of market access & health policy

January 1, 2015

p Therapeutic drug monitoring

c Economics Model
Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis.

b

Healthcare (Basel, Switzerland)

January 1, 2015

p Newborn Screening

c Economics Model
Cost effectiveness analysis of pharmacokinetically-guided 5-fluorouracil in FOLFOX chemotherapy for metastatic colorectal cancer.

b

Clinical colorectal cancer

December 1, 2014

p Therapeutic drug monitoring

c Economics Model
Modelling the potential population impact and cost-effectiveness of self-testing for HIV: evaluation of data requirements.

b

AIDS and behavior

July 1, 2014

p HIV POCT

c Economics Model
Procalcitonin, a valuable biomarker assisting clinical decision-making in the management of community-acquired pneumonia.

b

Internal medicine journal

April 1, 2014

p Antibiotic Guidance

c Model Operational efficiencies